Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $8.9400 (-9.79%) ($8.9300 - $9.8600) on Thu. Jun. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.19% (three month average) | RSI | 16 | Latest Price | $8.9400(-9.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -11.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(46%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -4.595% in a week (0% probabilities). VIXM(-32%) VXX(-28%) UNG(-10%) UUP(-9%) TLT(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.595% (StdDev 9.19%) | Hourly BBV | 0 () | Intraday Trend | -5.9% | | | |
|
1 - 5 Day Possible Target | $-16.24(-281.66%) | Resistance Level | $11.09 | 5 Day Moving Average | $9.84(-9.15%) | 10 Day Moving Average | $10.21(-12.44%) | 20 Day Moving Average | $11.09(-19.39%) | To recent high | -40.1% | To recent low | 57.1% | Market Cap | $664m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |